Introgen Files Advexin For Head And Neck Cancer In U.S., EU
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotech says it hopes to follow the Idec/Rituxan model in bringing oncologic gene therapy to the U.S. market.